Pages that link to "Q68072150"
Jump to navigation
Jump to search
The following pages link to Impact of adjuvant radiation on the patterns and rate of relapse in advanced-stage Hodgkin's disease treated with alternating chemotherapy combinations (Q68072150):
Displaying 24 items.
- The Role of Adjuvant Radiation Therapy for Stages III and IV Hodgkin's Disease (Q33862700) (← links)
- The contemporary use of radiation therapy in the management of lymphoma. (Q33942641) (← links)
- Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496) (Q34645722) (← links)
- Changing role and decreasing size: current trends in radiotherapy for Hodgkin's disease (Q34774184) (← links)
- Does radiotherapy still have a place in Hodgkin lymphoma? (Q37738583) (← links)
- Treatment of Hodgkin's disease: the role of radio- and/or chemotherapy in advanced stages (Q41217222) (← links)
- Radiation techniques for the treatment of Hodgkin's disease with combined modality therapy or radiation alone (Q41642751) (← links)
- Does the Addition of Involved Field Radiotherapy to High-Dose Chemotherapy and Stem Cell Transplantation Improve Outcomes for Patients With Relapsed/Refractory Hodgkin Lymphoma? (Q43600215) (← links)
- Treatment of patients with advanced or bulky Hodgkin disease with a 12-week doxorubicin, bleomycin, vinblastine, and dacarbazine-like chemotherapy regimen followed by extended-field, full-dose radiotherapy: long-term results of the Groupe Ouest et E (Q44202170) (← links)
- Analysis of treatment results in advanced Hodgkin's disease: the case for adjuvant radiotherapy (Q44466521) (← links)
- Active breathing control (ABC) for Hodgkin’s disease: reduction in normal tissue irradiation with deep inspiration and implications for treatment (Q61903126) (← links)
- Is anything better than MOPP? (Q70496897) (← links)
- High-dose therapy and autologous bone marrow transplantation for relapsed/refractory Hodgkin's disease: the impact of involved field radiotherapy on patterns of failure and survival (Q71571874) (← links)
- Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease (Q72054549) (← links)
- Integrating radiotherapy into bone marrow transplantation programs for Hodgkin's disease (Q72054631) (← links)
- Combined chemotherapy-radiotherapy in advanced Hodgkin's disease: Results of a prospective clinical trial with 70 stage IIIB-IV patients (Q72084223) (← links)
- PACE BOM chemotherapy: a 12-week regimen for advanced Hodgkin's disease (Q73311871) (← links)
- What is the optimal treatment volume in Hodgkin's disease patients undergoing high-dose chemotherapy and adjuvant radiation therapy? (Q73375441) (← links)
- Is combined modality therapy necessary for advanced Hodgkin's disease? (Q73531794) (← links)
- Salvage radiotherapy for hodgkin's disease following chemotherapy failure (Q73801771) (← links)
- Costs and effectiveness of staging and treatment options in early-stage Hodgkin's disease (Q74107248) (← links)
- Ten-year results of a strategy combining three cycles of ABVD and high-dose extended irradiation for treating Hodgkin's disease at advanced stages (Q74467039) (← links)
- [The role of radiotherapy in the management of advanced Hodgkin's disease] (Q77406542) (← links)
- Outcomes and relapse patterns following chemotherapy in advanced Hodgkin lymphoma in the positron emission tomography era (Q92276406) (← links)